MedPath

ALBUTEROL SULFATE

ALBUTEROL SULFATE Inhalation Aerosol, with Dose Indicator FOR ORAL INHALATION ONLY Prescribing Information

Approved
Approval ID

c4d6d76a-14b8-411a-8019-e2c923c2c532

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 29, 2023

Manufacturers
FDA

Cipla USA Inc.

DUNS: 078719707

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

albuterol sulfate

PRODUCT DETAILS

NDC Product Code69097-142
Application NumberANDA209959
Marketing CategoryC73584
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateMay 29, 2023
Generic Namealbuterol sulfate

INGREDIENTS (4)

ALBUTEROL SULFATEActive
Quantity: 90 ug in 1 1
Code: 021SEF3731
Classification: ACTIM
OLEIC ACIDInactive
Code: 2UMI9U37CP
Classification: IACT
NORFLURANEInactive
Code: DH9E53K1Y8
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALBUTEROL SULFATE - FDA Drug Approval Details